Next Article in Journal
Weizmannia coagulans SA9: A Novel Strategy to Alleviate Type 2 Diabetes
Previous Article in Journal
Purple Potato Extract Suppresses Hypoxia-Induced Metabolic Reprogramming and Inhibits HIF-1α Signaling in Caco-2 Cells
Previous Article in Special Issue
Cobalamin Status Among Patients with Fetal Alcohol Spectrum Disorder (FASD)—A Preliminary Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 17
Issue 13
10.3390/nu17132080
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Human Milk Oligosaccharide Composition at 6 Weeks Is Associated with Temperament and Eating Behaviors of Children in the STRONG Kids 2 Cohort Through 4 Years of Age

by
Yuting Fan
1,
Kelly F. Bost
2 and
Sharon M. Donovan
1,3,*
1
Department of Food Science and Human Nutrition, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA
2
Human Development and Family Studies, Department of Human Development and Family Studies, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA
3
Division of Nutritional Science, University of Illinois Urbana-Champaign, Urbana, IL 61801, USA
*
Author to whom correspondence should be addressed.
Nutrients 2025, 17(13), 2080; https://doi.org/10.3390/nu17132080
Submission received: 28 April 2025 / Revised: 6 June 2025 / Accepted: 21 June 2025 / Published: 23 June 2025
(This article belongs to the Special Issue The Role of Nutrients in Child Neurodevelopment)
Browse Figures
Versions Notes

Abstract

Background/Objectives: Early childhood is a critical window of development, which is influenced by early life exposures including breastfeeding. Observational and preclinical studies have linked human milk oligosaccharides (HMOs) with neurocognitive development. However, less attention has focused on behavioral outcomes including temperament and eating behaviors. Herein, we investigated the associations between HMO consumption and child temperament and child eating behaviors through four years of age. Methods: Participants were drawn from the STRONG Kids 2 cohort. Human milk was collected at 6 weeks postpartum, and HMO relative abundances were determined by HPLC-MS. Using validated questionnaires, child temperament was assessed at 3, 18, and 48 months of age, and child eating behaviors were measured at 12, 18, 24, 36, and 48 months of age. After adjusting for covariates, multiple linear regressions were carried out to assess the relationship between HMOs and the outcome measures. Results: The HMO profile of mothers showed two distinct clusters explained by maternal secretor status. Significant associations between HMO and surgency were only found in the full cohort and secretors, while more associations between HMO and negative affectivity were observed in non-secretors. A significant number of associations was observed between HMOs and child eating behaviors in full cohort, secretors, and non-secretors. HMO diversity, total fucosylation, and total sialylation were positively associated with food responsiveness, while neutral HMOs presented negative associations. However, these associations with food responsiveness were not observed in non-secretors. Conclusions: HMO profiles were associated with behavioral outcomes in the children, with variations by child age and maternal secretor status, highlighting the potential role of HMOs within the broader context of maternal and postnatal influences.

Graphical Abstract

1. Introduction

The first few years of life represent a critical and dynamic window for rapid growth and development [1], during which nutrition and environmental factors profoundly influence long-term cognitive [2] and behavioral development and health [3,4,5]. Human milk (HM) is the gold standard for infants by virtue of its short- and long-term health benefits [6]. Beyond meeting the nutritional needs of infants, HM plays an important role in immune protection [7], microbiome modulation [8], and cognitive development [9]. HM is a complex system that contains bioactive compounds, including 20–25 g/L of human milk oligosaccharides (HMOs) in colostrum and 5–20 g/L in mature HM [10,11]. HMOs are a structurally diverse group of carbohydrates that vary in composition among mothers [12]. The main compositional difference in HMO is driven by maternal genetics and secretor status, which is defined by the activity of the FUT2 gene that encodes the α 1,2 fucosyltransferase enzyme. This enzyme enables the attachment of fucose residues to HMOs with an α 1–2 linkage, such as 2′-fucosyllactose (2′-FL), which is present in high concentrations in secretor mothers. In contrast, non-secretor mothers lack functional FUT2 activity, resulting in a HMO profile with much lower or even absent levels of HMOs with α 1–2 linkages [12]. HMOs pass through the stomach and small intestine relatively intact until reaching the colon, where they exert their effects by modulating microbiota composition and function [13,14,15], reducing pathogen attachment to mucosal surfaces [16] and influencing systemic immunological responses [16,17].
Building on the beneficial roles of HMOs, they have been associated with infant neurocognitive development in recent years [18,19]. However, studies on the neurocognitive outcomes of HMO consumption in humans are underexplored, especially in terms of behavioral aspects. Also, no study to date has investigated associations between HMO composition and infant temperament or feeding behaviors. Temperament is considered a measure of personality [20]. Although there is no clear definition of the term, it is widely accepted as referring to the innate individual differences in responsiveness and self-regulation that emerge early in life, affect behavior, emotions, and attention, and remain relatively stable across the lifespan [21,22,23,24].
To assess the early life individual differences, three domains of temperament are usually measured: surgency, negative affectivity, and effortful control. Surgency, sometimes referred to as extraversion [25], is defined as an individual’s tendency toward positive emotions, sociability, and likelihood of engaging with others, seeking rewards, and enjoying high-energy activities [26]. Negative affectivity is the tendency to experience negative emotional states [27] and emotional stress, which can be associated with anxiety and depression [28]. Effortful control is the ability to inhibit a primary response in order to execute a secondary response [29] and reflects individual variations in the capacity to regulate emotions and behaviors in a self-directed manner [30]. Early life exposures are closely related to the later development of temperament [31,32].
Alongside temperament, early life eating behavior represents another crucial domain of child behavior that can be impacted by early environmental factors and can be linked to long-term health outcomes. The prevalence of childhood obesity has rapidly increased over the last few decades worldwide and has become a public health concern [33]. Obesity is a complex metabolic condition that can be attributed to various factors [34], including genetic predisposition, environmental impacts, dietary practices, family environment, lifestyles, socioeconomic status, etc. [35,36,37,38]. Among these, dietary patterns and eating behaviors play an important role in shaping weight status in childhood [39,40]. Eating behaviors involve the individual’s relationship with food and food consumption behaviors [41], which can include appetitive traits and food preferences [42]. Early eating behaviors establish a foundation for eating patterns and nutritional status later in life, which can be associated with eating disorders and the long-term risk of obesity [43]. Additionally, child temperament is significantly associated with eating behaviors [44,45]. Therefore, the primary objective of this study was to investigate relationships between early life exposure to HMO at 6 weeks postpartum and behavioral outcomes, including temperament and eating behaviors, through 4 years of age. We hypothesized that the relative abundances of sialylated and fucosylated HMOs at 6 weeks postpartum would be associated with infant and child temperament and eating behavior outcomes.

2. Materials and Methods

2.1. Participants and HMO Analysis

The participants are drawn from the STRONG Kids2 longitudinal birth cohort (IRB #13448) [46]. The STRONG Kids 2 cohort aims to identify early life determinants of growth and risk for childhood obesity. The participants were recruited from the central Illinois area in their third trimester of pregnancy (n = 468) [46]. From the entire cohort, 385 mothers who provided an HM sample at 6 weeks postpartum, and their breastfed babies were included in the current analysis. The method for HMO analysis using HPLC and the HMO profiles from the participants at 6 weeks postpartum were previously described [47]. Each HMO relative abundance was calculated as the proportion of each individual HMO relative to the total oligosaccharide content within each HM sample. The analysis included the relative abundances of the top 25 HMOs, HMO diversity, and the total relative abundance of the grouped sialylated, fucosylated, neutral, and non-fucosylated neutral HMOs. The participants reported breastfeeding exclusivity in online surveys at 1 week, 6 weeks, 3 months (mos), and 12 mos postpartum, which was used to estimate the breastfeeding duration. HMO relative abundances were normalized with the Gaussianization algorithm using the Lambert package in R (Version 4.2.1).

2.2. Covariates

Data were collected via online self-reported surveys [46]. Covariates include maternal age at delivery, pre-pregnancy BMI, maternal depression scores, maternal education level, and socioeconomic status at 6 weeks postpartum, infant birth weight, delivery mode, and breastfeeding duration. Maternal postnatal depression was measured by the Edinburgh Postnatal Depression Scale (EPDS) [48,49] at 6 weeks postpartum, which is the same time as the breast milk collection. The selection of covariates was based on data availability and previous literature to remove potential confounding.

2.3. Outcome Measures

When their child was 3 mos of age, the parent completed the Infant Behavior Questionnaire Revised-Very Short Form (IBQR-VS) [21,50], which measures infant temperament in three domains: surgency, negative affectivity, and effortful control. The effortful control component in infancy is labeled as “orienting/regulation” [51]. When the child was 18 and 48 mos old, the Early Childhood Behavior Questionnaire-Very Short (ECBQ-VS) [52,53] was completed to measure temperament in early childhood. The same three domains of temperament were assessed. The child’s early life eating behaviors were measured at 12 mos, 18 mos, and 2, 3, and 4 years old with the Children’s Eating Behaviour Questionnaire (CEBQ) [54]. This questionnaire has been validated across geographic locations around the world [55,56,57,58,59,60]. The CEBQ provides a practical measure of the child’s eating styles with a 35-item parent report questionnaire that generates eight scales, including “food approach” subscales (food responsiveness, enjoyment of food, emotion overeating, and desire to drink) and “food avoidant” subscales (food fussiness, slowness in eating, emotional undereating, and satiety responsiveness [54,55].

2.4. Statistical Analysis

All statistical analyses were performed in R (Version 4.2.1, R Foundation for Statistical Computing: Vienna, Austria, https://www.r-project.org/). Statistical significance was set at a p-value of ≤0.05. Multiple linear regression was used to assess the associations between HMO relative abundances and available outcome measures at each time point, including temperament as assessed by the IBQR-VS questionnaire and ECBQ-VS questionnaire, and child eating behaviors as assessed by the ECBQ questionnaire. A data matrix consisting of the top 25 HMOs was also analyzed with principal component analysis (PCA), a dimensionality reduction technique that transforms corrected variables into a smaller set of uncorrelated components, to identify patterns in HMO profiles in different mothers [61]. HMO relative abundances were log-transformed before analysis. Covariates were adjusted to control for potential confounding and were not independently tested as hypotheses [18]. All the categorical variables were standardized by one-hot encoding [62], and numerical variables were winsorized and standardized. Missing values were imputed before fitting into the models. Independence of residuals, homoscedasticity, and normality were not violated. Multiple testing was corrected using the Benjamini–Hochberg false discovery rate (FDR), where an adjusted p-value of ≤0.10 was considered significant. Given the exploratory nature of this study, we presented results both before and after applying FDR corrections.

3. Results

3.1. Summary Statistics for Demographic Information of the Participants

Descriptive statistics were computed for demographic information of the participants included in the current analysis. A summary of statistics is listed in Table 1.

3.2. HMO Clustering

A clear separation of samples was observed with PCA for the HMO composition of the mothers, suggesting inherent grouping within the dataset. The major differences between HMO profiles of the mothers are introduced by genetic variations or secretor status [63]. In our cohort, the secretor status explained 37.5% of the variation in HMO profiles (Figure 1). As previously reported, most of the top 25 most abundant HMO relative abundances varied by secretor status. Detailed information on the relative abundances of individual HMOs of secretor and non-secretor mothers was previously reported by Fan et. al. [18]. Therefore, in addition to analyzing the full cohort, associations between HMO relative abundances and the infant and child behavioral outcomes were examined within each secretor status group.

3.3. Associations Between HMO Profiles and Temperament Outcomes

Associations between HMO relative abundances and infant temperament were observed for all the sub-domains, with variations in the full cohort and by secretor status. Consistent with the terminology outlined in the Methods, we refer to the temperament domain of “effortful control” as “orienting/regulation” in infancy to reflect developmental changes in conceptualization. At 3 mos old, HMO diversity was found to be significantly associated with surgency (β = 0.128, p = 0.023), suggesting that higher HMO diversity is associated with increased surgency scores, but this was only observed in the full cohort. Individual neutral and fucosylated HMOs were also found to impact temperamental outcomes. Positive associations between 2′-FL and surgency scores were observed in both the full cohort and the secretor-only group. LNT+LNnT were negatively associated with infant surgency scores in the full cohort (p = 0.015) and in secretors (p = 0.036). Additionally, total nonfucosylated neutral HMOs (β = −0.127, p = 0.022) and LNFP I+LNFP III (β = −0.222, p = 0.021) are negatively associated with surgency scores in the full cohort. Conversely, non-secretors demonstrated unique positive associations between several fucosylated HMOs and infant negative affectivity, such as LNDFH I (β = 0.785, p = 0.010), and LNDFH 2 (β = 0.199, p = 0.029) (Table 2). However, after correcting for multiple testing, only the association between IFLNH III relative abundance and surgency scores at 3 mos remained statistically significant in the full cohort and secretors only (adjusted p = 0.08 and 0.04, respectively).
At 18 mos, the impact of HMOs on the surgency scores was less pronounced, and most effects were observed on effortful control and negative affectivity. However, at this point, the sialylated HMOs emerged as influencers for child temperamental outcomes. S-LNnH II appeared to be negatively associated with negative affectivity in the full cohort (β = −0.094, p = 0.009) and in non-secretors (β = −0.307, p = 0.002), suggesting that children of mothers with higher S-LNnH II relative abundances show lower negative affectivity. Total neutral HMO relative abundances were negatively associated with effortful control in the full cohort (β = −0.084, p = 0.040) and in secretors (β = −0.098, p = 0.045), but not in non-secretors. Furthermore, LNH appears to be negatively associated with negative affectivity at 18 mos old, which is consistent across the full cohort (β = −0.123, p = <0.001), secretors (β = −0.105, p = 0.040), and non-secretors (β = −0.150, p = 0.006). Interestingly, total sialylation was negatively associated with negative affectivity in non-secretors (β = −0.267, p = 0.002), indicating that sialylated HMOs, as a group, might be protective against negative affective behaviors. However, the finding diverged for one of the main sialylated HMOs, 3′-SL, which was positively associated with negative affectivity in non-secretors (β = 0.129, p = 0.034). The contrasting relationship suggests that the effects of sialylation on behavior are not uniform and could be influenced by the specific HMO (Table 3). After applying FDR correction, most of the associations at 18 mos of age were no longer significant in the full cohort and the secretors, except for the negative associations between LNH and negative affectivity in the full cohort (adjusted p = 0.02). Furthermore, a greater number of associations in non-secretors survived a 10% FDR correction, with total sialylation, S-LNnH II, and IFLNH III remaining negatively associated with negative affectivity (adjusted p = 0.1, 0.1, and 0.1, respectively).
We observed more associations between HMO relative abundances and temperamental outcomes in 4-year-old children. HMO structures containing lacto-N-hexaose (LNH) were consistently associated with negative affectivity in children, with notable differences by maternal secretor status. Specifically, in the full cohort, LNH, MFpLNH I+III, and DFLNHa all showed negative associations with negative affectivity. In secretors, MFpLNH I+III, and DFLNHa maintained their significant associations with negative affectivity in children. Similarly, in non-secretors, LNH, p-LNH, and MFpLNH I+III also exhibited negative associations with negative affectivity, further emphasizing the protective role of HMOs with similar structures. The only exception was noted for MFpLNH IV in non-secretors, which was positively associated with negative affectivity (Table 4). Additionally, FDR corrected results suggested that the negative associations between MFpLNH I+III and negative affectivity remained statistically significant in the full cohort (adjusted p = 0.009).
Overall, we observed that the associations between HMO and infant temperament varied based on maternal secretor status, with the effects on surgency being more pronounced in secretors and the effects on negative affectivity more pronounced in non-secretors (Figure A1, Figure A2 and Figure A3).

3.4. Associations Between HMO Profiles and Infant and Child Eating Behaviors

Eight subdomains of eating behaviors were investigated. Most scales were found to be associated with HMO composition at 6 weeks postpartum. In the full cohort at 12 mos of age, 6′-SL relative abundance was positively associated with enjoyment of food (β = 0.086, p = 0.028) and negatively associated with emotional undereating (β = −0.178, p < 0.001), suggesting the potential of 6′-SL to promote food and energy intake. In non-secretors, 6′-SL was also negatively associated with slowness in eating (β = −0.119, p = 0.032), further confirming the effect of 6′-SL to promote eating. Total sialylated HMO relative abundances were negatively associated with emotional undereating across the groups, which presents a consistent effect with 6′-SL. LNFP I + III relative abundances were negative predictors for enjoyment of food in the full cohort (β = −0.183, p = 0.018) and secretors (β = −0.201, p = 0.006), suggesting the potential to reduce food intake (Table 5). With FDR correction, the negative association between 6′-SL relative abundance and child emotional undereating behavior remained significant in the full cohort and in secretors (adjusted p = 0.09 and 0.014, respectively). In non-secretors, only the positive association between DFS-LNnH and emotional overeating continued to show significance (adjusted p = 0.08).
When the children were 18 mos old, the effects of 6′-SL on slowness in eating in the full cohort and secretors were still observed. Additionally, the relative abundance or total non-fucosylated neutral HMOs was a negative predictor for emotional overeating behavior (β = −0.066, p = 0.031) in the full cohort and food responsiveness in the secretors (β = −0.166, p = 0.002). LNDFH II was negatively associated with food fussiness in the full cohort (β = −0.141, p = 0.022) and in secretors (β = −0.278, p = 0.016). Total sialylation abundances were negatively associated with slowness in eating (β = −0.080, p = 0.040) and emotional undereating (β = −0.120, p = 0.029) in the full cohort and secretors (β = −0.088, p = 0.046 and β = −0.161, p = 0.008, respectively) (Table 6). However, the observed effects failed to withstand FDR correction.
When the children were 2 years old, some effects seen at earlier time points were still present. For instance, in the full cohort, total sialylation continued to be positively associated with enjoyment of food (β = 0.086, p = 0.045) and negatively associated with the “food avoidant” behaviors, including satiety responsiveness (β = −0.071, p = 0.038) and slowness in eating (β = −0.083, p = 0.037). Similar traits were also observed in secretors, but not in non-secretors. One of the most abundant sialylated HMOs, 6′-SL, displayed negative relationships with slowness in eating and emotional undereating in the full cohort and in secretors. Another sialylated HMO, S-LNH, was a positive predictor of emotional overeating and food responsiveness, and a negative predictor of satiety responsiveness and slowness in eating. These collectively suggest a role of S-LNH in promoting food intake, which is consistent with the relationship found for total sialylation. Total grouped abundances of the total non-fucosylated neutral HMOs were negatively associated with emotional overeating (β = −0.084, p = 0.015) and desire to drink (β = −0.121, p = 0.050) in the full cohort, suggesting their protective potential in unhealthy overeating behaviors (Table 7). However, after FDR corrections, the associations found at 24 mos were no longer statistically significant.
At 36 mos old, distinct effects of 3-FL between the secretor and the non-secretor groups were observed. Specifically, in the full cohort, 3-FL was positively associated with desire-to-drink behaviors and a tendency to approach sweetened beverages, which may contribute to higher caloric intake (β = 0.190, p = 0.012). This positive association was also significant within the secretor group (β = 0.231, p = 0.034). Conversely, in non-secretors, 3-FL demonstrated opposing effects. Higher relative abundances of 3-FL were negatively associated with enjoyment of food (β = −0.212, p = 0.007) and positively associated with satiety responsiveness (β = 0.203, p = < 0.001). Thus, depending on secretor status, 3-FL may play a role in modulating appetite and feeding behaviors differently (Table 8). It is important to note, however, that the findings fall below the threshold of significance after subsequent FDR correction.
The pattern of associations between HMOs and eating behaviors at 48 mos resembled that of 36-month-old children, suggesting more stabilized eating behaviors in early childhood. However, the effects of the total fucosylated HMO abundance on eating behaviors observed at 36 mos of age were no longer present (Table 9). Furthermore, the findings at 48 mos also failed to withstand FDR adjustment for multiple comparisons.
In summary, many associations were identified between HMO profiles and child eating behavior sub-domains. Some distinct patterns were seen in secretors and non-secretors. For example, most effects of HMO on food responsiveness were observed in secretors, while most effects on satiety responsiveness were found in non-secretors (Figure A4, Figure A5 and Figure A6). However, most of the associations were no longer significant after correcting for multiple testing (Table 10). Only several associations remained to be associated with emotional eating behaviors at 12 mos.

4. Discussion

Herein, associations between HMO composition and infant temperament and eating behaviors were investigated in the STRONG Kids 2 cohort. HMOs have been associated with various aspects of neurocognitive development in intervention trials in preclinical animal models, as well as in association studies in human infants [18,19]. However, the effects of HMO on the development of temperament traits and eating behaviors are underexplored. While our initial analyses revealed a great number of associations between HMO profile and infant behavioral outcomes, many did not remain statistically significant following FDR corrections for individual HMO and behavior sub-domains. However, given the lack of extant data, the unadjusted findings can also help inform future studies in this area.
Temperament development in early childhood is vital to how children respond to and interact with the environment around them [64] and predicts later personality and behaviors [65], including psychopathology [66]. We first investigated and found associations between maternal HMO compositions at 6 weeks postpartum and child temperamental traits (surgency, effortful control, and negative affectivity), with variations among maternal secretor status and child ages. During infancy, 2′-FL and LNnH positively affected surgency and effortful control (orienting/regulation) in the full cohort and infants of mothers who are secretors, but these associations did not persist through childhood. In the total cohort, positive relationships between HMO diversity and infant surgency scores were only observed at 3 mos. Additionally, common associations between similarly structured HMO relative abundances and temperamental outcomes were found, but some differences in directionality of these relationships were noted.
Sialylated HMOs have been associated with neurocognitive development [67] and anxiety reduction [68]. The sialic acid component has been suggested to up-regulate the mRNA levels in the hippocampus and liver for sialic acid biosynthesis. Sialic acid is an essential part of brain gangliosides that modulate dopamine receptor function [69], influencing early childhood temperament development [70,71]. Therefore, we investigated the effects of sialylated HMOs on infant and child temperamental outcomes. Indeed, total sialylated HMOs were negatively associated with negative affectivity in non-secretors at 18 and 48 mos old, which supported the mood-regulating effects of sialic acid. Furthermore, the sialylated HMO, S-LNnH II, was also negatively associated with negative affectivity in the full cohort and in non-secretors when the children were 18 mos old. However, 3′-SL showed an opposite effect in non-secretors at 18 mos old. Likewise, several LNH-containing HMOs, including LNH, MFpLNH I+III, and DFLNHa, consistently showed negative associations with negative affectivity across the full cohort, secretors, and non-secretors. In the full cohort, negative associations between LNH and negative affectivity at 18 mos and negative associations between MFLNH I+III and negative affectivity at 48 mos survived 10% FDR correction, further suggesting the similar effects of LNH-containing HMOs. The exception was MFpLNH IV, which exhibited positive associations with negative affectivity, mirroring the variability we observed for 3′-SL and suggesting the complexity of HMO-behavioral interactions.
Given that HMOs have been observed to exhibit potential effects on temperament, it is crucial to further investigate this early life nutritional exposure on other behavioral aspects, including eating patterns. CEBQ is a validated measurement for child eating behaviors that involves eight sub-scales. Those sub-scales have been extensively reported to be an important predictor for the later development of obesity. Food responsiveness and enjoyment of food are positive predictors of increased weight-for-length z scores in infancy, and slowness in eating is a negative predictor [72,73]. Satiety responsiveness was reported to be a negative predictor for child BMI z scores [74]. In the STRONG Kids 2 cohort, we identified associations between HMO relative abundances and eating behavior sub-scales.
Plows et al. explored the associations between HMO composition and child eating behaviors, and this was the only other study that considered child eating behavior as an outcome measurement [75]. Their study utilized the Baby Eating Behaviour Questionnaire (BEBQ), an adaptation of the CEBQ for younger babies. Eating behaviors were assessed at 1 and 6 mos of age via the parent report survey. The authors reported that LNnT was negatively associated with food responsiveness in the total sample [75]. In our cohort, Negative associations were also observed between LNT+LNnT relative abundance in the full cohort at 12 mos, at 18 mos, and in secretors. Plows et al. also reported that at 6 mos, FLNH, LNH, and DSLNH were positively associated with food responsiveness in both the total sample and secretors only [75]. Similarly, in our cohort, we discovered positive associations between HMO structures with the LNH component and food responsiveness subdomain at younger ages close to the sampling times of the authors, although these results did not survive the FDR corrections. For example, at 12 mos of age, DFS-LNH and TFLNH were positively associated with food responsiveness in the full cohort and secretors; S-LNnH II and MFpLNH IV were positively associated with food responsiveness in secretors only. At 24 mos old, S-LNH was positively associated with food responsiveness in the full cohort and secretors. These results provided additional evidence of the potential positive associations between LNH residue and overeating behaviors.
Children of mothers with pre-pregnancy overweight and obesity have been reported to at higher risk for childhood obesity [76], and it has been suggested that feeding practices may serve as the mechanism for intergeneration transmission of obesity [76,77]. To contextualize our current findings, we revisited our study on maternal determinants of HMO composition. Our previous analysis in this cohort showed that 3-FL and LNFP V were negatively associated with maternal pre-pregnancy BMI in non-secretor mothers [47]. In the current analysis, we observed that when the children are 18 mos old, 3-FL relative abundances were negative predictors for enjoyment of food and positive predictors for satiety responsiveness. These associations suggest that higher 3-FL abundances may play a protective role against overeating behaviors in children, a relationship that persists consistently at 24, 36, and 48 mos, but this was only seen in non-secretors. At 24 mos old, LNFP V also appeared to be negatively associated with enjoyment of food and positively associated with satiety responsiveness. Furthermore, we previously demonstrated that higher LNT and LNnT relative abundance is associated with lower maternal obesity [47], and we found that greater LNT and LNnT abundance is associated with lower food responsiveness behavior in children at 12 and 18 mos old. These eating behaviors could potentially, in turn, reduce the risk of developing childhood obesity. Furthermore, it has been suggested that maternal BMI is a positive predictor for the concentration of 6′-SL [78]. In the present study, the association for eating behaviors that remained significant after FDR correction is the negative association between 6‘-SL relative abundance and emotional undereating behavior when the child is 1 year old (adjusted p-value = 0.014), suggesting an opposite effect of 6′-SL on food avoidance actions. Thus, we can hypothesize that maternal pre-pregnancy BMI could indirectly impact the child’s risk of obesity in childhood via HMO composition and subsequent behavioral outcomes, warranting further investigation.
Additionally, in the STRONG Kids 2 cohort, we investigated the impacts of pregnancy complications, including Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus (GDM). We discovered that mothers who developed GDM showed higher relative abundances of individual HMOs, including LDFT, LNDFH I, LNnH, S-LNnH II, and DFS-LNH [47]. In the current study, some of these HMOs were also associated with child eating behaviors at 2 years of age. For instance, in the total cohort and among secretors, LDFT and DFS-LNH were positively associated with enjoyment of food, whereas LNnH and S-LNnH II were negatively associated with emotional undereating behaviors. Interestingly, LNDFH I was found to be protective against the emotional overeating behavior. Although these findings highlight both connections and discrepancies, it is still worth noting the potential of maternal-infant interactions on child development through the modulation of HMO composition in breastmilk, emphasizing the need for further investigation in this area. It has been reported that there is a link between maternal GDM and offspring overweight and obesity [79,80]. This increased risk of childhood obesity in children born to mothers with GDM reflects the fetal programming [81,82]. Maternal metabolic conditions like obesity or inflammatory conditions, including GDM, might alter the bioactive components such as HMO composition in breastmilk [83,84]
Surprisingly, although we identified a protective potential of 3-FL in excessive eating behaviors in non-secretors, a different relationship was observed in the full cohort and in secretors. This may suggest that 3-FL influences behaviors through distinct pathways based on maternal genetic background and secretor status. Such findings highlight the importance of considering individual variations when examining the effects of HMO on child development. It has previously been reported that the milk microbiome can vary largely by maternal secretor status [63]. It has also been suggested that the extent of HMO impact on child developmental outcomes also depends on maternal secretor status [85].
Across the time points for the eating behavior assessment, we observed associations between LNFP II relative abundances and “food avoidant” behaviors such as satiety responsiveness, suggesting the potential of LNFP II to protect from childhood obesity. This is in agreement with Berger et al. [86], who reported that higher LNFP II predicts lower weight-for-age z scores at 6 mos. Although this relationship is more pronounced in older ages after 18 mos and did not survive FDR corrections, the potential of LNFP II for preventing rapid weight gain in early life is still worth noting.
Overall, we defined variations in the effects of HMO on temperament and eating behaviors, which could potentially be attributed to the interaction of HMO with gut microbiome, the complexity of HMO metabolites, and the gut–brain axis. The gut–brain axis is the bidirectional interaction between the gut and the brain, which regulates physiological functions including mood, immune functions, and food intake [87,88]. Several infant gut bacterial species can metabolize HMOs and produce metabolites, including short-chain fatty acids (SCFAs) [89]. SCFAs can increase the expression of blood–brain barrier tight junctions and then reduce the permeability [90]. Appetite and energy intake can also be regulated via SCFA-stimulated hormonal and neuronal signals [91]. Additionally, SCFAs such as butyrate and acetate can upregulate the serotonin pathway, and serotonin is a neurotransmitter that regulates the mood and appetite [92]. Therefore, HMO can potentially exert effects on child temperament and eating behaviors via the regulation of SCFA production.
We also found that the effects of HMO on eating behaviors were quite consistent between 3 and 4 years old, which further supports the hypothesis that the effects of HMO were achieved via the modulation of the gut microbiome, as the gut microbiome composition is likely to become relatively stable beyond 3 years of age [93]. The links between gut microbiome environment and eating behaviors via the gut–brain axis have been well studied in adults [94,95,96]. However, studies on younger children in this area are relatively limited. Berding et al. also mentioned in their analysis of the associations between gut microbiome composition and dietary patterns that the differences in the children’s dietary patterns were associated with unique microbiome compositions. A dietary pattern that contains refined carbohydrates, sweetened beverages, snacks, and sweets was linked to a higher relative abundance of Bacteroidetes, Bacteroides, and Ruminococcus, along with a lower abundance of Bifidobacterium, Prevotella, Blautia, and Roseburia [97]. The microbiome patterns are likely influenced by the HMO composition and, then, influence child feeding patterns in turn. For example, with our knowledge of the ability of Bifidobacterium longum subsp. infantis to utilize HMOs, including 3-FL [98], the positive associations observed between satiety response and 3-FL relative abundances might be partially explained by the promotion of Bifidobacterium growth. Thus, it will be valuable to further investigate the mediating role of gut microbiome in the relationships between HMO profile and child eating behaviors, which is currently under investigation in our cohort.
Additionally, child temperament can influence eating behavior development [99] and childhood obesity risk [100]. For example, children with a temperament style marked by greater negative affectivity were at greater risk of developing unhealthful eating patterns [101], supporting the results observed in the STRONG Kids2 cohort at 4 years of age. Lower negative affectivity was observed in children of non-secretors who had consumed HMO with higher LNH relative abundances. At the same time, lower emotional overeating scores were also found in children who consumed a greater abundance of LNH, suggesting the potential protective role of LNH in unhealthy eating behavior development and childhood obesity.
While our findings suggest associations between HMO exposure at 6 weeks postpartum and child behavioral outcomes, we were unable to interpret those relationships as causal. The composition of HMOs is determined by a range of complex factors, including genetics, epigenetic regulation, environmental factors, dietary habits, and health status. These maternal factors may also affect child development via additional biological interactions. Furthermore, HMOs might exert effects on child development via indirect pathways such as the gut–brain axis. Future research integrating multi-omics data will be needed to disentangle the complex interactions.

Strengths and Limitations

A strength of the current study was the ability to obtain infant and child behavioral outcomes at multiple time points up to 4 years of age with a high participant retention rate, allowing us to explore the impact of early life exposures over a critical development window. Additionally, the focus of the study on the impact of HMO composition on behavioral traits provides a unique perspective on the effects of early life nutrition on child development trajectories.
This study also has some limitations. First, our study population has a relatively high level of education and socioeconomic status, which may not fully represent the broader population. Also, HMO profiles were reported as a relative abundance of the total HMO composition rather than the absolute concentration, which did not allow estimation of actual amounts of individual HMO intake by the infants. Moreover, we only had HM samples available at one time point and were not able to quantify the changes in HMO concentrations across all stages of lactation. Lastly, given the limited number of prior studies in this area, the current analysis was conducted in an exploratory framework. Separate regression analyses were performed for each time point and subscale measures for behavioral outcomes with the purpose of providing an initial understanding of the potential relationships between HMO exposure and infant behavioral development. After the implementation of a 10% FDR correction for multiple testing, fewer associations remained significant. Thus, the results of this analysis need to be considered as tentative and interpreted for hypothesis generation for further studies.

5. Conclusions

This study provides insights into the associations between the HMO composition at 6 weeks postpartum and subsequent infant and child temperament and eating behavior outcomes. Our findings suggest that individual HMOs and grouped HMOs relative abundances, as well as HMO diversity, may shape early behavioral traits and feeding patterns. However, the effect of HMOs varies by maternal secretor status and child age. The traits of temperament and eating behaviors are important in the early developmental period, as they can set the foundations for lifelong dietary habits and can play a role in the development of obesity and metabolic disorders.

Author Contributions

Conceptualization, Y.F. and S.M.D.; methodology, Y.F.; software, R Studio; formal analysis, Y.F.; investigation, S.M.D.; data curation, Y.F.; writing—original draft preparation, Y.F.; writing—review and editing, S.M.D. and K.F.B.; visualization, Y.F.; supervision, S.M.D. and K.F.B.; project administration, S.M.D.; funding acquisition, S.M.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Dairy Council, the National Institutes of Health (R01 DK107561), the Gerber Foundation, and USDA Hatch funding (ILLU-698-979). YF was supported by the Jeanette Chu and Winston Y. Lo Endowed Fellowship from the Department of Food Science and Human Nutrition at the University of Illinois Urbana-Champaign and a Dissertation Completion Fellowship from the Graduate College at the University of Illinois Urbana-Champaign.

Institutional Review Board Statement

The Institutional Review Board (#13448) of the University of Illinois Urbana-Champaign reapproved the study annually; the last approval date was 11 January 2024.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Parents provided informed consent for themselves and their child.

Data Availability Statement

The data presented in this study are available on request from the corresponding author due to privacy reasons.

Acknowledgments

The authors thank the STRONG Kids Research Team (University of Illinois Urbana-Champaign) for assistance with study recruitment and sample collection and Marcia Monaco for support with sample processing.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
2′-FL2′-Fucosyllactose
3-FL3-Fucosyllactose
3′-SL3′-Sialyllactose
6′-SL6′-Sialyllactose
LNnTLacto-N-neotetraose
LNTLacto-N-tetrose
LDFTLactodifucotetraose
LNFP I/II/III/VLacto-N-fucopentaose-I/II/III/V
DFLNHa/bDifucosyllacto-N-hexaose a/b
LNDFH I/IILacto-N-difucohexaose I/II
LNHLacto-N-hexaose
LNnHLacto-N-neohexaose
p-LNHPara-lacto-N-hexaose
S-LNHSialyl-lacto-N-hexaose
S-LNnH IISialyllacto-N-neohexaose II
MFpLNH IVFucosyl-para-lacto-N-hexaose IV
MFLNH I + IIIMonofucosyllacto-N-hexaose I/III
IFLNH I/IIIFucosyl-para-lacto-N-hexaose I/III
DFS-LNHDifucosylmonosialyllacto-N-hexaose
DFS-LNnHDifucosylmonosialyllacto-N-neohexaose
TFLNHTrifucosyllacto-N-hexaose
HMOHuman Milk Oligosaccharides
HPLC-MSHigh performance liquid chromatography-mass spectrometry
BMIBody Mass Index
EPDSEdinburgh Postnatal Depression Scale
IBQR-VSInfant Behavior Questionnaire Revised-Very Short
ECBQ-VSEarly Childhood Behavior Questionnaire-Very Short
CEBQChildren’s Eating Behaviour Questionnaire
BEBQBaby Eating Behaviour Questionnaire
yr(s)Year/Years
mo(s)Month/Months
FRFood responsiveness
EUEEmotional undereating
FFFood fussiness
SESlowness in eating
SRSatiety responsiveness;
DDDesire to drink
EOEEmotional overeating
GDMGestational diabetes mellitus
SCFAsShort-chain fatty acids

Appendix A

Nutrients 17 02080 g0a1
Figure A1. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child temperament sub-domain scores in full cohort (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose.
Figure A1. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child temperament sub-domain scores in full cohort (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose.
Nutrients 17 02080 g0a1
Nutrients 17 02080 g0a2
Figure A2. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child temperament sub-domain scores in secretors (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/ III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose.
Figure A2. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child temperament sub-domain scores in secretors (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/ III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose.
Nutrients 17 02080 g0a2
Nutrients 17 02080 g0a3
Figure A3. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child temperament sub-domain scores in non-secretors (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non -significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose.
Figure A3. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child temperament sub-domain scores in non-secretors (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non -significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose.
Nutrients 17 02080 g0a3
Nutrients 17 02080 g0a4
Figure A4. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child eating behavior sub-domain scores in full cohort (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. Stars indicated statistical significance after FDR correction. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose; FR, food responsiveness; EUE, emotional undereating; FF, food fussiness; SE, slowness in eating; SR, satiety responsiveness; DD, desire to drink; EOE, emotional overeating.
Figure A4. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child eating behavior sub-domain scores in full cohort (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. Stars indicated statistical significance after FDR correction. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose; FR, food responsiveness; EUE, emotional undereating; FF, food fussiness; SE, slowness in eating; SR, satiety responsiveness; DD, desire to drink; EOE, emotional overeating.
Nutrients 17 02080 g0a4
Nutrients 17 02080 g0a5
Figure A5. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child eating behavior sub-domain scores in secretors (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose; FF, food fussiness; SE, slowness in eating; SR, satiety responsiveness; DD, desire to drink; EOE, emotional overeating.
Figure A5. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child eating behavior sub-domain scores in secretors (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose; FF, food fussiness; SE, slowness in eating; SR, satiety responsiveness; DD, desire to drink; EOE, emotional overeating.
Nutrients 17 02080 g0a5
Nutrients 17 02080 g0a6
Figure A6. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child eating behavior sub-domain scores in non-secretors (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose; FF, food fussiness; SE, slowness in eating; SR, satiety responsiveness; DD, desire to drink; EOE, emotional overeating.
Figure A6. Heat map depicting the significant associations between HMO relative abundances at 6 weeks postpartum and child eating behavior sub-domain scores in non-secretors (unadjusted). Multiple linear regressions were used after correcting for covariates. Associations that were statistically significant are shown in colors, with color intensity representing the strength and direction of the relationship. Non-significant associations are indicated in white-colored cells. Red colors indicate positive beta coefficients and purple colors indicate negative beta coefficient. HMO, human milk oligosaccharide; 2′-FL, 2′-fucosyllactose; 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/II/III/V, lacto-N-fucopentaose-I/II/III/V; DFLNHa/b, difucosyllacto-N-hexaose a/b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose; FF, food fussiness; SE, slowness in eating; SR, satiety responsiveness; DD, desire to drink; EOE, emotional overeating.
Nutrients 17 02080 g0a6

References

  1. Wadsworth, M.; Butterworth, S. Early life. In Social Determinants of Health, 2nd ed; Marmot, T.M., Wilkinson, R.G., Eds.; Oxford University Press: Oxford, UK, 2006; ISBN 9780198565895. [Google Scholar]
  2. Prado, E.L.; Dewey, K.G. Nutrition and brain development in early life. Nutr. Rev. 2014, 72, 267–284. [Google Scholar] [CrossRef] [PubMed]
  3. McEwen, B.S. Early life influences on life-long patterns of behavior and health. Ment. Retard. Dev. Disabil. Res. Rev. 2003, 9, 149–154. [Google Scholar] [CrossRef] [PubMed]
  4. Tregellas, J.R.; Legget, K.T. Rapid early brain development highlights a critical period and possible intervention window. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2020, 5, 937–938. [Google Scholar] [CrossRef]
  5. Gilmore, J.H.; Knickmeyer, R.C.; Gao, W. Imaging structural and functional brain development in early childhood. Nat. Rev. Neurosci. 2018, 19, 123–137. [Google Scholar] [CrossRef] [PubMed]
  6. Meek, J.Y.; Noble, L.; Breastfeeding, S.O. Policy statement: Breastfeeding and the use of human milk. Pediatrics 2022, 150, e2022057988. [Google Scholar] [CrossRef]
  7. Xanthou, M. Immune protection of human milk. Biol. Neonate 1998, 74, 121–133. [Google Scholar] [CrossRef]
  8. Carr, L.E.; Virmani, M.D.; Rosa, F.; Munblit, D.; Matazel, K.S.; Elolimy, A.A.; Yeruva, L. Role of human milk bioactives on infants’ gut and immune health. Front. Immunol. 2021, 12, 604080. [Google Scholar] [CrossRef]
  9. Anatolitou, F. Human milk benefits and breastfeeding. J. Pediatr. Neonatal Individ. Med. (JPNIM) 2012, 1, 11–18. [Google Scholar]
  10. Xu, G.; Davis, J.C.; Goonatilleke, E.; Smilowitz, J.T.; German, J.B.; Lebrilla, C.B. Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation. J. Nutr. 2017, 147, 117–124. [Google Scholar] [CrossRef]
  11. Soyyılmaz, B.; Mikš, M.H.; Röhrig, C.H.; Matwiejuk, M.; Meszaros-Matwiejuk, A.; Vigsnæs, L.K. The mean of milk: A review of human milk oligosaccharide concentrations throughout lactation. Nutrients 2021, 13, 2737. [Google Scholar] [CrossRef]
  12. Vinjamuri, A.; Davis, J.C.; Totten, S.M.; Wu, L.D.; Klein, L.D.; Martin, M.; Quinn, E.; Scelza, B.; Breakey, A.; Gurven, M. Human milk oligosaccharide compositions illustrate global variations in early nutrition. J. Nutr. 2022, 152, 1239–1253. [Google Scholar] [CrossRef] [PubMed]
  13. Coppa, G.V.; Bruni, S.; Morelli, L.; Soldi, S.; Gabrielli, O. The first prebiotics in humans: Human milk oligosaccharides. J. Clin. Gastroenterol. 2004, 38, S80–S83. [Google Scholar] [CrossRef] [PubMed]
  14. Walsh, C.; Lane, J.A.; van Sinderen, D.; Hickey, R.M. Human milk oligosaccharides: Shaping the infant gut microbiota and supporting health. J. Funct. Foods 2020, 72, 104074. [Google Scholar] [CrossRef] [PubMed]
  15. Sánchez, C.; Fente, C.; Regal, P.; Lamas, A.; Lorenzo, M.P. Human milk oligosaccharides (HMOs) and infant microbiota: A scoping review. Foods 2021, 10, 1429. [Google Scholar] [CrossRef]
  16. Donovan, S.M.; Comstock, S.S. Human milk oligosaccharides influence neonatal mucosal and systemic immunity. Ann. Nutr. Metab. 2016, 69, 41–51. [Google Scholar] [CrossRef]
  17. Triantis, V.; Bode, L.; Van Neerven, R.J. Immunological effects of human milk oligosaccharides. Front. Pediatr. 2018, 6, 190. [Google Scholar] [CrossRef]
  18. Fan, Y.; McMath, A.L.; Donovan, S.M. Review on the impact of milk oligosaccharides on the brain and neurocognitive development in early life. Nutrients 2023, 15, 3743. [Google Scholar] [CrossRef]
  19. Berger, P.K.; Ong, M.L.; Bode, L.; Belfort, M.B. Human milk oligosaccharides and infant neurodevelopment: A narrative review. Nutrients 2023, 15, 719. [Google Scholar] [CrossRef]
  20. Sesker, A.A.; Strickhouser, J.E.; Luchetti, M.; Lee, J.H.; Aschwanden, D.; Terracciano, A.; Sutin, A.R. Cognition and the development of temperament from late childhood to early adolescence. J. Res. Pers. 2021, 95, 104163. [Google Scholar] [CrossRef]
  21. Rothbart, M.K.; Derryberry, D. Development of individual differences in temperament. In Advances in Developmental Psychology; Psychology Press: London, UK, 2013; pp. 37–86. [Google Scholar]
  22. Kristal, J. The Temperament Perspective: Working with Children’s Behavioral Styles; Paul H Brookes Publishing: Baltimore, MD, USA, 2005. [Google Scholar]
  23. Henderson, H.A.; Wachs, T.D. Temperament theory and the study of cognition–emotion interactions across development. Dev. Rev. 2007, 27, 396–427. [Google Scholar] [CrossRef]
  24. Rothbart, M.K. Measurement of temperament in infancy. Child Dev. 1981, 52, 569–578. [Google Scholar] [CrossRef]
  25. Burton, P.; Wells, J.; Kennedy, K.; Nicholl, R.; Khakoo, A.; Fewtrell, M. Association between infant correlates of impulsivity-surgency (extraversion)-and early infant growth. Appetite 2011, 57, 504–509. [Google Scholar] [CrossRef] [PubMed]
  26. Holmboe, K. The construct of surgency. In Encyclopedia of Personality and Individual Differences; Springer: Cham, Switzerland, 2016; pp. 1–6. [Google Scholar] [CrossRef]
  27. Watson, D.; Clark, L.A. Negative affectivity: The disposition to experience aversive emotional states. Psychol. Bull. 1984, 96, 465. [Google Scholar] [CrossRef]
  28. King, N.J.; Ollendick, T.H.; Gullone, E. Negative affectivity in children and adolescents: Relations between anxiety and depression. Clin. Psychol. Rev. 1991, 11, 441–459. [Google Scholar] [CrossRef]
  29. Rothbart, M.K.; Ellis, L.K.; Rosario Rueda, M.; Posner, M.I. Developing mechanisms of temperamental effortful control. J. Pers. 2003, 71, 1113–1144. [Google Scholar] [CrossRef]
  30. Rueda, M.R. Effortful control. In Handbook of Temperament; The Guilford Press: New York, NY, USA, 2012; pp. 145–167. [Google Scholar]
  31. Gartstein, M.A.; Skinner, M.K. Prenatal influences on temperament development: The role of environmental epigenetics. Dev. Psychopathol. 2018, 30, 1269–1303. [Google Scholar] [CrossRef]
  32. Suryawan, A.; Jalaludin, M.Y.; Poh, B.; Sanusi, R.; Tan, V.; Geurts, J.; Muhardi, L. Malnutrition in early life and its neurodevelopmental and cognitive consequences: A scoping review. Nutr. Res. Rev. 2022, 35, 136–149. [Google Scholar] [CrossRef]
  33. Umekar, S.; Joshi, A. Obesity and Preventive Intervention Among Children: A Narrative Review. Cureus 2024, 16, e54520. [Google Scholar] [CrossRef]
  34. Chooi, Y.C.; Ding, C.; Magkos, F. The epidemiology of obesity. Metabolism 2019, 92, 6–10. [Google Scholar] [CrossRef]
  35. Schmidt, I.; Schoelch, C.; Ziska, T.; Schneider, D.; Simon, E.; Plagemann, A. Interaction of genetic and environmental programming of the leptin system and of obesity disposition. Physiol. Genomics 2000, 3, 113–120. [Google Scholar] [CrossRef]
  36. Lee, H.; Lee, I.S.; Choue, R. Obesity, inflammation and diet. Pediatr. Gastroenterol. Hepatol. Nutr. 2013, 16, 143–152. [Google Scholar] [CrossRef] [PubMed]
  37. Dinsa, G.D.; Goryakin, Y.; Fumagalli, E.; Suhrcke, M. Obesity and socioeconomic status in developing countries: A systematic review. Obes. Rev. 2012, 13, 1067–1079. [Google Scholar] [CrossRef]
  38. Bates, C.; Buscemi, J.; Nicholson, L.; Cory, M.; Jagpal, A.; Bohnert, A. Links between the organization of the family home environment and child obesity: A systematic review. Obes. Rev. 2018, 19, 716–727. [Google Scholar] [CrossRef] [PubMed]
  39. Demir, D.; Bektas, M. The effect of childrens’ eating behaviors and parental feeding style on childhood obesity. Eat. Behav. 2017, 26, 137–142. [Google Scholar] [CrossRef]
  40. Obregón, A.M.; Pettinelli, P.P.; Santos, J.L. Childhood obesity and eating behaviour. J. Pediatr. Endocrinol. Metab. 2015, 28, 497–502. [Google Scholar] [CrossRef]
  41. Peuckert, M.Z.; Ayala, C.O.; Mattiello, R.; Viola, T.W.; Walker, M.S.; Feoli, A.M.P.; Drumond Costa, C.A. Validation evidence for the Children’s Eating Behaviour Questionnaire (CEBQ) in Brazil: A cross-sectional study. Nutrients 2025, 17, 851. [Google Scholar] [CrossRef]
  42. Fildes, A.; Mallan, K.M.; Cooke, L.; Van Jaarsveld, C.H.; Llewellyn, C.H.; Fisher, A.; Daniels, L. The relationship between appetite and food preferences in British and Australian children. Int. J. Behav. Nutr. Phys. Act. 2015, 12, 116. [Google Scholar] [CrossRef]
  43. Herle, M.; De Stavola, B.; Hübel, C.; Abdulkadir, M.; Ferreira, D.S.; Loos, R.J.; Bryant-Waugh, R.; Bulik, C.M.; Micali, N. A longitudinal study of eating behaviours in childhood and later eating disorder behaviours and diagnoses. Br. J. Psychiatry 2020, 216, 113–119. [Google Scholar] [CrossRef] [PubMed]
  44. Steinsbekk, S.; Bjørklund, O.; Llewellyn, C.; Wichstrøm, L. Temperament as a predictor of eating behavior in middle childhood–A fixed effects approach. Appetite 2020, 150, 104640. [Google Scholar] [CrossRef]
  45. Messerli-Bürgy, N.; Stülb, K.; Kakebeeke, T.H.; Arhab, A.; Zysset, A.E.; Leeger-Aschmann, C.S.; Schmutz, E.A.; Meyer, A.H.; Ehlert, U.; Garcia-Burgos, D. Emotional eating is related with temperament but not with stress biomarkers in preschool children. Appetite 2018, 120, 256–264. [Google Scholar] [CrossRef]
  46. Fiese, B.H.; Musaad, S.; Bost, K.K.; McBride, B.A.; Lee, S.-Y.; Teran-Garcia, M.; Donovan, S.M. The Strong Kids 2 birth cohort study: A cell-to-society approach to dietary habits and weight trajectories across the first 5 years of life. Curr. Dev. Nutr. 2019, 3, nzz007. [Google Scholar] [CrossRef] [PubMed]
  47. Fan, Y.; Vinjamuri, A.; Tu, D.; Lebrilla, C.B.; Donovan, S.M. Determinants of human milk oligosaccharides profiles of participants in the STRONG kids 2 cohort. Front. Nutr. 2023, 10, 1105668. [Google Scholar] [CrossRef]
  48. Cox, J.; Holden, J. Perinatal Mental Health: A Guide to the Edinburgh Postnatal Depression Scale (EPDS); Royal College of Psychiatrists: London, England, 2003. [Google Scholar]
  49. Levis, B.; Negeri, Z.; Sun, Y.; Benedetti, A.; Thombs, B.D. Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) for screening to detect major depression among pregnant and postpartum women: Systematic review and meta-analysis of individual participant data. BMJ 2020, 371, m4022. [Google Scholar] [CrossRef] [PubMed]
  50. Shamseddeen, W.; Bou Ali, L.; El Bejjani, M.; Safieddine, B.; Abou Chaar, E.; Akoury Dirani, L. Infant and Toddler Emotion and Behavior Regulation Evaluation Tools: Infant Behavior Questionnaire–Revised (IBQR) and the Early Childhood Behavior Questionnaire-Short (ECBQ-S); Technical Working Paper; American University of Beirut: Beirut, Lebanon, 2019. [Google Scholar]
  51. Putnam, S.P.; Helbig, A.L.; Gartstein, M.A.; Rothbart, M.K.; Leerkes, E. Development and assessment of short and very short forms of the Infant Behavior Questionnaire–Revised. J. Pers. Assess. 2014, 96, 445–458. [Google Scholar] [CrossRef] [PubMed]
  52. Hwang, Y.-S. A validation study for the Early Childhood Behavior Questionnaire. Korean J. Child Stud. 2009, 30, 191–204. [Google Scholar]
  53. Putnam, S.P.; Gartstein, M.A.; Rothbart, M.K. Measurement of fine-grained aspects of toddler temperament: The Early Childhood Behavior Questionnaire. Infant. Behav. Dev. 2006, 29, 386–401. [Google Scholar] [CrossRef]
  54. Wardle, J.; Guthrie, C.A.; Sanderson, S.; Rapoport, L. Development of the children’s eating behaviour questionnaire. J. Child Psychol. Psychiatry 2001, 42, 963–970. [Google Scholar] [CrossRef]
  55. Sleddens, E.F.; Kremers, S.P.; Thijs, C. The Children’s Eating Behaviour Questionnaire: Factorial validity and association with Body Mass Index in Dutch children aged 6–7. Int. J. Behav. Nutr. Phys. Act. 2008, 5, 49. [Google Scholar] [CrossRef] [PubMed]
  56. Viana, V.; Sinde, S.; Saxton, J. Children’s Eating Behaviour Questionnaire: Associations with BMI in Portuguese children. Br. J. Nutr. 2008, 100, 445–450. [Google Scholar] [CrossRef]
  57. Domoff, S.E.; Miller, A.L.; Kaciroti, N.; Lumeng, J.C. Validation of the Children’s Eating Behaviour Questionnaire in a low-income preschool-aged sample in the United States. Appetite 2015, 95, 415–420. [Google Scholar] [CrossRef]
  58. Mallan, K.M.; Liu, W.-H.; Mehta, R.J.; Daniels, L.A.; Magarey, A.; Battistutta, D. Maternal report of young children’s eating styles. Validation of the Children’s Eating Behaviour Questionnaire in three ethnically diverse Australian samples. Appetite 2013, 64, 48–55. [Google Scholar] [CrossRef] [PubMed]
  59. Cao, Y.-T.; Svensson, V.; Marcus, C.; Zhang, J.; Zhang, J.-D.; Sobko, T. Eating behaviour patterns in Chinese children aged 12-18 months and association with relative weight-factorial validation of the Children’s Eating Behaviour Questionnaire. Int. J. Behav. Nutr. Phys. Act. 2012, 9, 5. [Google Scholar] [CrossRef] [PubMed]
  60. Obregón, A.M.; Valladares, M.; Guzmán-Gutierrez, E.; Pettinelli, P.; Hunot-Alexander, C.; Smith, A.; Llewellyn, C.; Goldfield, G. Validation of the baby eating behaviour questionnaire in a Chilean population. Curr. Psychol. 2024, 43, 5377–5387. [Google Scholar] [CrossRef]
  61. Kurita, T. Principal component analysis (PCA). In Computer Vision: A Reference Guide; Springer: Berlin/Heidelberg, Germany, 2021; pp. 1013–1016. [Google Scholar]
  62. Seger, C. An Investigation of Categorical Variable Encoding Techniques in Machine Learning: Binary Versus One-Hot and Feature Hashing. Bachelor’s Thesis, School of Electrical Engineering and Computer Science (EECS), Stockholm, Sweden, 2018. [Google Scholar]
  63. Cabrera-Rubio, R.; Kunz, C.; Rudloff, S.; García-Mantrana, I.; Crehuá-Gaudiza, E.; Martínez-Costa, C.; Collado, M.C. Association of maternal secretor status and human milk oligosaccharides with milk microbiota: An observational pilot study. J. Pediatr. Gastroenterol. Nutr. 2019, 68, 256–263. [Google Scholar] [CrossRef] [PubMed]
  64. Carey, W.B. The importance of temperament-environment interaction for child health and development. In The Uncommon Child; Springer: Berlin/Heidelberg, Germany, 1981; pp. 31–55. [Google Scholar]
  65. Alving-Jessep, E.; Botchway, E.; Wood, A.G.; Hilton, A.C.; Blissett, J.M. The development of the gut microbiome and temperament during infancy and early childhood: A systematic review. Dev. Psychobiol. 2022, 64, e22306. [Google Scholar] [CrossRef]
  66. Nigg, J.T. Temperament and developmental psychopathology. J. Child Psychol. Psychiatry 2006, 47, 395–422. [Google Scholar] [CrossRef]
  67. ten Bruggencate, S.J.; Bovee-Oudenhoven, I.M.; Feitsma, A.L.; van Hoffen, E.; Schoterman, M.H. Functional role and mechanisms of sialyllactose and other sialylated milk oligosaccharides. Nutr. Rev. 2014, 72, 377–389. [Google Scholar] [CrossRef]
  68. Tarr, A.J.; Galley, J.D.; Fisher, S.E.; Chichlowski, M.; Berg, B.M.; Bailey, M.T. The prebiotics 3′ Sialyllactose and 6′ Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations: Evidence for effects on the gut–brain axis. Brain Behav. Immun. 2015, 50, 166–177. [Google Scholar] [CrossRef]
  69. Tilson, H.; Harry, G.; Nanry, K.; Hudson, P.; Hong, J. Ganglioside interactions with the dopaminergic system of rats. J. Neurosci. Res. 1988, 19, 88–93. [Google Scholar] [CrossRef]
  70. Nyman, E.S.; Loukola, A.; Varilo, T.; Ekelund, J.; Veijola, J.; Joukamaa, M.; Taanila, A.; Pouta, A.; Miettunen, J.; Freimer, N. Impact of the dopamine receptor gene family on temperament traits in a population-based birth cohort. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2009, 150, 854–865. [Google Scholar] [CrossRef]
  71. Sheese, B.E.; Voelker, P.M.; Rothbart, M.K.; Posner, M.I. Parenting quality interacts with genetic variation in dopamine receptor D4 to influence temperament in early childhood. Dev. Psychopathol. 2007, 19, 1039–1046. [Google Scholar] [CrossRef] [PubMed]
  72. Shepard, D.N.; Chandler-Laney, P.C. Prospective associations of eating behaviors with weight gain in infants. Obesity 2015, 23, 1881–1885. [Google Scholar] [CrossRef] [PubMed]
  73. Harris, S.J.; Paul, I.M.; Anzman-Frasca, S.; Savage, J.S.; Hohman, E.E. Protective Eating Behaviors Among Children at Higher Risk for Obesity in the INSIGHT Study. Child. Obes. 2024, 21, 76–83. [Google Scholar] [CrossRef]
  74. Cummings, J.R.; Lipsky, L.M.; Faith, M.S.; Nansel, T.R. Developmental trajectory of appetitive traits and their bidirectional relations with body mass index from infancy to early childhood. Clin. Obes. 2024, 14, e12620. [Google Scholar] [CrossRef]
  75. Plows, J.F.; Berger, P.K.; Jones, R.B.; Yonemitsu, C.; Ryoo, J.H.; Alderete, T.L.; Bode, L.; Goran, M.I. Associations between human milk oligosaccharides (HMOs) and eating behaviour in Hispanic infants at 1 and 6 months of age. Pediatr. Obes. 2020, 15, e12686. [Google Scholar] [CrossRef] [PubMed]
  76. Mannino, A.; Sarapis, K.; Moschonis, G. The effect of maternal overweight and obesity pre-pregnancy and during childhood in the development of obesity in children and adolescents: A systematic literature review. Nutrients 2022, 14, 5125. [Google Scholar] [CrossRef]
  77. Schneider-Worthington, C.R.; Berger, P.K.; Goran, M.I.; Salvy, S.J. Learning to overeat in infancy: Concurrent and prospective relationships between maternal BMI, feeding practices and child eating response among Hispanic mothers and children. Pediatr. Obes. 2021, 16, e12756. [Google Scholar] [CrossRef]
  78. Saben, J.L.; Sims, C.R.; Abraham, A.; Bode, L.; Andres, A. Human milk oligosaccharide concentrations and infant intakes are associated with maternal overweight and obesity and predict infant growth. Nutrients 2021, 13, 446. [Google Scholar] [CrossRef]
  79. Kim, S.Y.; Sharma, A.J.; Callaghan, W.M. Gestational diabetes and childhood obesity: What is the link? Curr. Opin. Obstet. Gynecol. 2012, 24, 376–381. [Google Scholar] [CrossRef] [PubMed]
  80. Plagemann, A.; Harder, T.; Kohlhoff, R.; Rohde, W.; Dörner, G. Overweight and obesity in infants of mothers with long-term insulin-dependent diabetes or gestational diabetes. Int. J. Obes. Relat. Metab. Disord. 1997, 21, 451–456. [Google Scholar] [CrossRef]
  81. Choi, M.J.; Yu, J.; Choi, J. Maternal pre-pregnancy obesity and gestational diabetes mellitus increase the risk of childhood obesity. Children 2022, 9, 928. [Google Scholar] [CrossRef] [PubMed]
  82. Mantzorou, M.; Papandreou, D.; Pavlidou, E.; Papadopoulou, S.K.; Tolia, M.; Mentzelou, M.; Poutsidi, A.; Antasouras, G.; Vasios, G.K.; Giaginis, C. Maternal gestational diabetes is associated with high risk of childhood overweight and obesity: A cross-sectional study in pre-school children aged 2–5 years. Medicina 2023, 59, 455. [Google Scholar] [CrossRef]
  83. Thum, C.; Wall, C.R.; Weiss, G.A.; Wang, W.; Szeto, I.M.-Y.; Day, L. Changes in HMO concentrations throughout lactation: Influencing factors, health effects and opportunities. Nutrients 2021, 13, 2272. [Google Scholar] [CrossRef] [PubMed]
  84. Bode, L. Human milk oligosaccharides: Next-generation functions and questions. In Human Milk: Composition, Clinical Benefits and Future Opportunities; Karger Publishers: Basel, Switzerland, 2019; Volume 90, pp. 191–201. [Google Scholar]
  85. Mulinge, M.M.; Abisi, H.K.; Kabahweza, H.M.; Okutoyi, L.; Wamalwa, D.C.; Nduati, R.W. The role of maternal secretor status and human milk oligosaccharides on early childhood development: A systematic review and meta-analysis. Breastfeed. Med. 2024, 19, 409–424. [Google Scholar] [CrossRef]
  86. Berger, P.; Plows, J.; Jones, R.; Alderete, T.; Yonemitsu, C.; Ryoo, J.H.; Bode, L.; Goran, M. Human milk oligosaccharides and Hispanic infant weight gain in the first 6 months. Obesity 2020, 28, 1519–1525. [Google Scholar] [CrossRef]
  87. Mayer, E.A.; Nance, K.; Chen, S. The gut–brain axis. Annu. Rev. Med. 2022, 73, 439–453. [Google Scholar] [CrossRef]
  88. Margolis, K.G.; Cryan, J.F.; Mayer, E.A. The microbiota-gut-brain axis: From motility to mood. Gastroenterology 2021, 160, 1486–1501. [Google Scholar] [CrossRef] [PubMed]
  89. Kiely, L.J.; Busca, K.; Lane, J.A.; van Sinderen, D.; Hickey, R.M. Molecular strategies for the utilisation of human milk oligosaccharides by infant gut-associated bacteria. FEMS Microbiol. Rev. 2023, 47, fuad056. [Google Scholar] [CrossRef]
  90. Braniste, V.; Al-Asmakh, M.; Kowal, C.; Anuar, F.; Abbaspour, A.; Tóth, M.; Korecka, A.; Bakocevic, N.; Ng, L.G.; Kundu, P. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 2014, 6, 263ra158. [Google Scholar] [CrossRef]
  91. Chambers, E.S.; Morrison, D.J.; Frost, G. Control of appetite and energy intake by SCFA: What are the potential underlying mechanisms? Proc. Nutr. Soc. 2015, 74, 328–336. [Google Scholar] [CrossRef] [PubMed]
  92. Deng, Y.; Zhou, M.; Wang, J.; Yao, J.; Yu, J.; Liu, W.; Wu, L.; Wang, J.; Gao, R. Involvement of the microbiota-gut-brain axis in chronic restraint stress: Disturbances of the kynurenine metabolic pathway in both the gut and brain. Gut Microbes 2021, 13, 1869501. [Google Scholar] [CrossRef] [PubMed]
  93. Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222–227. [Google Scholar] [CrossRef]
  94. Barone, M.; Garelli, S.; Rampelli, S.; Agostini, A.; Matysik, S.; D’Amico, F.; Krautbauer, S.; Mazza, R.; Salituro, N.; Fanelli, F. Multi-omics gut microbiome signatures in obese women: Role of diet and uncontrolled eating behavior. BMC Med. 2022, 20, 500. [Google Scholar] [CrossRef]
  95. Butler, M.J.; Perrini, A.A.; Eckel, L.A. The role of the gut microbiome, immunity, and neuroinflammation in the pathophysiology of eating disorders. Nutrients 2021, 13, 500. [Google Scholar] [CrossRef] [PubMed]
  96. Alcock, J.; Maley, C.C.; Aktipis, C.A. Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays 2014, 36, 940–949. [Google Scholar] [CrossRef]
  97. Berding, K.; Holscher, H.D.; Arthur, A.E.; Donovan, S.M. Fecal microbiome composition and stability in 4-to 8-year old children is associated with dietary patterns and nutrient intake. J. Nutr. Biochem. 2018, 56, 165–174. [Google Scholar] [CrossRef]
  98. Zhang, B.; Li, L.-Q.; Liu, F.; Wu, J.-Y. Human milk oligosaccharides and infant gut microbiota: Molecular structures, utilization strategies and immune function. Carbohydr. Polym. 2022, 276, 118738. [Google Scholar] [CrossRef] [PubMed]
  99. Bergmeier, H.; Skouteris, H.; Horwood, S.; Hooley, M.; Richardson, B. Child temperament and maternal predictors of preschool children’s eating and body mass index. A prospective study. Appetite 2014, 74, 125–132. [Google Scholar] [CrossRef]
  100. Faith, M.S.; Hittner, J.B.; Hurston, S.R.; Yin, J.; Greenspan, L.C.; Quesenberry, C.P.; Gunderson, E.P.; Investigators, S.O.S. Association of infant temperament with subsequent obesity in young children of mothers with gestational diabetes mellitus. JAMA Pediatr. 2019, 173, 424–433. [Google Scholar] [CrossRef]
  101. Kidwell, K.M.; James, T.D.; Brock, R.L.; Lazarus Yaroch, A.; Hill, J.L.; Mize Nelson, J.; Alex Mason, W.; Andrews Espy, K.; Nelson, T.D. Preschool executive control, temperament, and adolescent dietary behaviors. Ann. Behav. Med. 2023, 57, 260–268. [Google Scholar] [CrossRef]
Nutrients 17 02080 g001
Figure 1. The variations of the top 25 human milk oligosaccharide (HMO) composition of mothers by secretor status using principal component analysis (PCA). Each point represents one maternal HMO profile. Secretor (blue circles, n = 276) and non-secretor (red circles, n = 109) groups are shown. The first two principal components (PC1 and PC2) are plotted, explaining 37.5% and 18.7% of the variance, respectively. The separation between the two circled groups reflects differences in overall HMO composition associated with the maternal secretor status.
Figure 1. The variations of the top 25 human milk oligosaccharide (HMO) composition of mothers by secretor status using principal component analysis (PCA). Each point represents one maternal HMO profile. Secretor (blue circles, n = 276) and non-secretor (red circles, n = 109) groups are shown. The first two principal components (PC1 and PC2) are plotted, explaining 37.5% and 18.7% of the variance, respectively. The separation between the two circled groups reflects differences in overall HMO composition associated with the maternal secretor status.
Nutrients 17 02080 g001
Table 1. Summary statistics of demographic information in the STRONG Kids 2 cohort.
Table 1. Summary statistics of demographic information in the STRONG Kids 2 cohort.
Characteristicn (%) or Mean ± SD
Maternal age (yrs)31.2 ± 4.2
Pre-pregnancy BMI26.3 ± 6.2
Maternal depression EPDS score (on a scale of 0–30)4.3 ± 4.0
Infant birthweight (g)3492.7 ± 428.4
Infant sex assigned at birth
   Female179 (46.5%)
   Male206 (53.5%)
Secretor status
   Secretor276 (71.7%)
   Non-secretor109 (28.3%)
Delivery mode
   Cesarean section88 (22.9%)
   Vaginal294 (76.4%)
   Missing3 (0.8%)
Maternal education level at enrollment
   Grade school/some high school/high school graduate13 (3.4%)
   Some college or technical school56 (14.5%)
   College graduate/post-graduate work303 (78.7%)
   Missing13 (3.4%)
Socioeconomic status (monthly income)
   USD 3000 and under97 (25.2%)
   USD 3001–5000104 (27.0%)
   USD 5001 and above136 (35.3%)
   Missing48 (12.5%)
Maternal Ethnicity
   Hispanic/Latino15 (3.9%)
   Non-Hispanic/Latino Unknown or Mixed61 (15.8%)
   Non-Hispanic/Latino White285 (74.0%)
   Missing24 (6.2%)
Child Ethnicity
   Hispanic/Latino19 (4.9%)
   Non-Hispanic/Latino Unknown or Mixed74 (19.2%)
   Non-Hispanic/Latino White270 (70.1%)
   Missing22 (5.7%)
Exclusive Breastfeeding duration
   6 weeks24 (6.2%)
   3 mos107 (27.8%)
   12 mos197 (51.2%)
   Mixed feeding (human milk and formula)49 (12.7%)
   Missing8 (2.1%)
Abbreviations: mos, months; yrs, years; SD, standard deviation; BMI, body mass index; EPDS, Edinburgh Postnatal Depression Scale.
Table 2. Associations between HMO and temperament at three months of age (unadjusted for false discovery).
Table 2. Associations between HMO and temperament at three months of age (unadjusted for false discovery).
SampleTemperament CharacteristicHMOEstimatep-Values
Full cohortSurgencyHMO Diversity0.1280.023
Total non-fucosylated neutral−0.1270.022
2′-FL0.2040.028
LNT+LNnT−0.1450.015
LNFP I+LNFP III−0.2220.021
LNnH0.1270.025
IFLNH III0.164<0.001
Orienting/
Regulation 		LNnH0.1010.014
IFLNH III0.0730.039
SecretorsSurgency2′-FL0.2290.015
LNT+LNnT−0.1750.036
LNnH0.1230.046
MFpLNH IV0.2340.024
IFLNH III0.224<0.001
Orienting/
Regulation 		LNnH0.1080.014
Non-SecretorsNegative
affectivity		LNFP V0.2880.016
LNDFH I0.7850.010
LNDFH II0.1990.029
MFpLNH IV0.1680.046
DFLNHb0.2090.028
Abbreviations: 2′-FL, 2′-fucosyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LNFP I/III/V, lacto-N-fucopentaose-I/III/V; DFLNHb, difucosyllacto-N-hexaose b; LNDFH I/II, lacto-N-difucohexaose I/II; LNnH, lacto-N-neohexaose; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; IFLNH III, fucosyl-para-lacto-N-hexaose III.
Table 3. Associations between HMO and temperament at 18 months of age (unadjusted for false discovery).
Table 3. Associations between HMO and temperament at 18 months of age (unadjusted for false discovery).
SampleTemperament
Characteristic		HMOEstimatep-Values
Full CohortSurgencyp-LNH0.1040.012
Effortful controlNeutral−0.0840.040
Negative affectivityLNH−0.123<0.001
S-LNnH II−0.0940.009
SecretorsEffortful controlNeutral−0.0980.045
6′-SL−0.0920.038
LDFT−0.1050.040
Negative affectivity3-FL0.1420.018
LNH−0.1050.014
Non-SecretorsNegative affectivityTotal Sialylation−0.2670.002
3′-SL0.1290.034
LNH−0.1500.006
LNnH−0.2840.019
S-LNnH II−0.3070.002
IFLNH III−0.1590.003
Abbreviations: 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LDFT, lactodifucotetraose; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose; IFLNH III, fucosyl-para-lacto-N-hexaose III.
Table 4. Associations between HMO and temperament at 48 months of age (unadjusted for false discovery).
Table 4. Associations between HMO and temperament at 48 months of age (unadjusted for false discovery).
SampleTemperament
Characteristic		HMOEstimatep-Values
Full cohortSurgencyDFS-LNH−0.1230.026
Negative affectivityLNFP V0.2200.008
LNDFH I0.1570.007
LNDFH II0.2080.002
LNH−0.1180.008
MFpLNH I+III−0.198<0.001
DFLNHa−0.1680.004
SecretorsNegative affectivityLNFP II0.1970.025
LNDFH I0.1360.022
LNDFH II0.2750.030
MFpLNH I+III−0.2060.004
DFLNHa−0.1730.003
Non-SecretorsEffortful controlNeutral−0.1790.033
LNFP II−0.1800.012
LNDFH II−0.1720.047
DFS-LNnH1.9880.050
Negative affectivityTotal Sialylation −0.2800.020
LNFP V0.3090.012
LNDFH I0.7670.011
LNDFH II0.2310.012
LNH−0.1760.019
p-LNH−0.2120.044
MFpLNH IV0.1740.048
MFpLNH I+III−0.1900.018
Abbreviations: LNFP II/V, lacto-N-fucopentaose-II/V; DFLNHa, difucosyllacto-N-hexaose a; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; p-LNH, para-lacto-N-hexaose; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose.
Table 5. Associations between HMO and eating behaviors at 12 months of age (unadjusted for false discovery).
Table 5. Associations between HMO and eating behaviors at 12 months of age (unadjusted for false discovery).
SampleEating BehaviorHMOEstimatep-Values
Full CohortEnjoyment of food6′-SL0.0860.028
LNFP I+III−0.1830.018
DFS-LNH0.1140.019
Food fussinessHMO Diversity 0.0480.038
Emotional undereatingTotal Sialylation −0.1580.004
6′-SL−0.178<0.001
LDFT−0.1560.032
Food responsivenessNeutral−0.0940.025
LNT+LNnT−0.0960.043
DFS-LNnH0.0960.033
SecretorsEnjoyment of food3-FL0.1860.008
LDFT0.1100.047
LNFP I+III−0.2010.006
IFLNH I−0.1090.022
DFS-LNH0.1080.021
TFLNH0.0950.047
Desire to drinkTotal nonfucosylated neutral−0.1800.021
LNT+LNnT−0.1980.025
Food fussinessHMO Diversity0.0880.002
LNT+LNnT−0.0800.011
IFLNH III0.0580.016
Emotional undereatingTotal Sialylation−0.1760.005
Total nonfucosylated neutral0.1820.020
6′-SL−0.250<0.001
3′-SL−0.1900.003
LDFT−0.1720.023
LNT+LNnT0.1830.039
Food responsivenessHMO Diversity0.1380.021
Non-SecretorsEmotional overeatingLNH−0.0790.016
LNnH−0.1830.016
S-LNnH II−0.1420.015
DFS-LNH0.3960.026
DFS-LNnH1.482<0.001
Slowness in eatingTotal Sialylation−0.1720.029
6′-SL−0.1190.032
LDFT4.360.031
Desire to drinkLDFT7.470.022
IFLNH I−1.3830.014
Emotional undereatingTotal Sialylation−0.2910.017
LDFT6.240.046
LNDFH II0.1910.028
LNH−0.2020.006
LNnH−0.4730.006
p-LNH−0.2480.016
S-LNnH II−0.3350.011
DFS-LNH0.8510.033
Food responsivenessDFS-LNH0.7110.036
Abbreviations: 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP I/III, lacto-N-fucopentaose-I/III; LNDFH II, lacto-N-difucohexaose II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; p-LNH, para-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/ III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose.
Table 6. Associations between HMO and eating behaviors at 18 months (unadjusted for false discovery).
Table 6. Associations between HMO and eating behaviors at 18 months (unadjusted for false discovery).
SampleEating BehaviorHMOEstimatep-Values
Full CohortEnjoyment of foodDFS-LNH0.0890.050
Emotional overeatingTotal Nonfucosylated neutral−0.0660.031
Satiety responsivenessMFpLNH IV0.0990.022
DFLNHb0.0940.045
Slowness in eatingTotal Sialylation−0.0800.040
6′-SL−0.0840.017
LNFP II0.0940.035
Food fussinessLNDFH II−0.1410.022
LNH−0.0900.030
Emotional undereatingTotal Sialylation−0.1200.029
LNDFH I0.1420.039
LNH−0.1120.029
S-LNnH II−0.1340.017
Food responsivenessLNT+LNnT−0.0910.050
DFS-LNH0.0930.042
TFLNH0.0970.041
SecretorsEnjoyment of food3′-SL0.1000.028
DFS-LNH0.1140.011
Slowness in eatingTotal Sialylation−0.0880.046
6′-SL−0.0970.027
Emotional undereating Total Sialylation−0.1610.008
Neutral0.1420.041
6′-SL−0.1280.034
S-LNnH II−0.1300.035
Food fussinessNeutral0.1200.029
LNDFH II−0.2780.016
Food responsivenessHMO Diversity0.1630.005
Total Sialylation0.0950.030
Neutral−0.1250.012
Total nonfucosylated neutral−0.1660.002
LNT+LNnT−0.1910.002
S-LNnH II0.0910.040
MFpLNH IV0.1570.049
DFS-LNH0.1000.025
TFLNH0.1130.014
Non-SecretorsEnjoyment of food3-FL−0.2030.014
Emotional overeating3′-SL0.0920.035
S-LNnH II−0.1510.038
MFpLNH IV−0.1170.012
IFLNH III−0.0910.028
DFS-LNH0.4340.044
Satiety responsivenessTotal Fucosylation0.2610.005
3-FL0.1680.013
MFpLNH IV0.1650.007
DFLNHb0.1420.032
Emotional undereatingLNH−0.1710.045
Food fussinessLNH−0.1860.005
LNnH−0.3640.014
Abbreviations: 3-FL, 3-fucosyllactose; 3′-SL, 3′-sialyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LNFP II, lacto-N-fucopentaose-II; DFLNHb, difucosyllacto-N-hexaose b; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; IFLNH III, fucosyl-para-lacto-N-hexaose III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; TFLNH, trifucosyllacto-N-hexaose.
Table 7. Associations between HMO and eating behaviors at 24 months (unadjusted for false discovery).
Table 7. Associations between HMO and eating behaviors at 24 months (unadjusted for false discovery).
SampleEating BehaviorHMOEstimatep-Values
Full cohortEnjoyment of foodTotal Sialylation0.0860.045
LDFT0.1830.001
DFS-LNH0.1400.003
Emotional overeatingTotal Nonfucosylated neutral−0.0840.015
LNDFH I−0.0880.035
S-LNH0.0780.018
DFLNHa0.0850.044
Desire to drinkHMO Diversity0.1340.031
Total Nonfucosylated neutral−0.1210.050
LNT+LNnT−0.1500.023
Satiety responsivenessTotal Sialylation−0.0710.038
Neutral0.0790.017
LNFP II0.1200.002
S-LNH−0.0930.007
DFS-LNnH−0.0890.012
Slowness in eatingTotal Sialylation−0.0830.037
6′-SL−0.0770.032
S-LNH−0.0990.014
DFS-LNnH−0.0940.025
Emotional undereating6′-SL−0.1030.030
Food responsivenessS-LNH0.0960.024
SecretorsEnjoyment of foodLDFT0.1630.004
DFS-LNH0.1530.001
Emotional overeatingTotal nonfucosylated neutral−0.1010.018
LNFP II−0.1260.036
S-LNH0.0720.026
Satiety responsivenessTotal Sialylation−0.0760.043
S-LNH−0.0760.028
Slowness in eatingTotal Sialylation−0.1040.020
Neutral0.1130.023
6′-SL−0.1000.022
S-LNH−0.0940.022
Emotional undereating6′-SL−0.1250.030
Food responsivenessHMO Diversity0.1320.024
Total Sialylation0.1270.005
Neutral−0.1100.027
Total nonfucosylated neutral−0.1440.009
LNT+LNnT−0.1640.008
S-LNH0.0940.022
S-LNnH II0.1140.012
Non-SecretorsEnjoyment of foodNeutral−0.2140.011
3-FL−0.1900.026
LNFP V−0.3030.009
LNDFH II−0.1950.021
Emotional overeatingIFLNH III−0.1160.034
Desire to drinkHMO Diversity0.2110.035
Total nonfucosylated neutral−0.2290.026
LNT+LNnT−0.2540.017
MFLNH I+III−0.2160.019
Satiety responsivenessTotal Fucosylation0.2310.010
Neutral0.1330.033
3-FL0.1440.022
LNFP II0.1490.003
LNFP V0.1690.048
LNDFH II0.1350.031
Emotional undereatingLNH−0.1850.021
LNnH−0.3680.040
S-LNnH II−0.3210.031
Food fussinessMFLNH I+III−0.1670.027
DFS-LNH0.9050.021
Food responsivenessLNnH−0.3400.041
S-LNnH II−0.3490.011
IFLNH III−0.2310.002
IFLNH I−1.1860.024
Abbreviations: 3-FL, 3-fucosyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP II/V, lacto-N-fucopentaose-II/V; DFLNHa, difucosyllacto-N-hexaose a; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFLNH I/III, monofucosyllacto-N-hexaose I/III; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose.
Table 8. Associations between HMOs and eating behaviors at 36 months (unadjusted for false discovery).
Table 8. Associations between HMOs and eating behaviors at 36 months (unadjusted for false discovery).
SampleEating BehaviorHMOEstimatep-Values
Full CohortEnjoyment of FoodTotal Sialylation0.0890.037
6′-SL0.1090.004
LDFT0.1450.009
LNFP II−0.1010.036
Emotional overeatingIFLNH III−0.0770.028
Desire to drink6′-SL0.1700.002
3-FL0.1900.012
Satiety responsivenessTotal Sialylation−0.0690.046
LNFP II0.1160.003
Slowness in eatingLNFP II0.1160.014
LNDFH I0.1040.047
IFLNH I−0.0940.049
DFLNHb0.1390.015
TFLNH0.1040.033
Food fussinessLDFT−0.1640.006
LNT+LNnT0.1130.032
DFS-LNnH−0.1370.004
Emotional undereatingTotal Sialylation−0.1080.045
LNFP II0.1490.014
LNFP V0.1890.049
Food responsiveness6′-SL0.0780.048
SecretorsEnjoyment of foodTotal Sialylation0.0910.049
6′-SL0.1420.002
LDFT0.1470.007
Emotional overeatingTotal fucosylation0.1500.015
Desire to drink6′-SL0.1680.011
3-FL0.2310.034
Satiety responsivenessIFLNH III−0.0930.022
Slowness in eatingTotal Sialylation−0.0900.046
LNFP II0.2100.006
MFpLNH IV0.1830.024
DFLNHb0.2190.014
Food fussinessHMO Diversity−0.1630.015
Total Fucosylation−0.1730.027
Total nonfucosylated neutral0.1590.012
6′-SL−0.1100.031
LDFT−0.1700.005
LNT+LNnT0.2050.004
p-LNH0.1220.020
DFS-LNnH−0.1390.003
Emotional undereating6′-SL−0.1190.038
LNFP II0.1980.046
Food responsivenessTotal Fucosylation0.1340.049
6′-SL0.0890.043
Non-SecretorsEnjoyment of foodTotal Fucosylation−0.2700.022
3-FL−0.2120.007
LNFP II−0.1360.039
LNDFH II−0.1930.016
p-LNH0.2370.005
Emotional overeatingLDFT6.8970.019
S-LNnH II−0.2190.024
IFLNH III−0.1550.014
DFS-LNH0.6640.045
Satiety responsivenessHMO Diversity0.1400.017
Total Fucosylation0.2930.001
3-FL0.203<0.001
LNFP II0.1350.007
p-LNH−0.1500.024
DFLNHb0.1290.050
Emotional undereatingDFS-LNH0.9600.046
Food fussinessLNDFH I0.6060.028
Abbreviations: 3-FL, 3-fucosyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LDFT, lactodifucotetraose; LNFP II/V, lacto-N-fucopentaose-II/V; DFLNHb, difucosyllacto-N-hexaose b; LNDFH I/II, lacto-N-difucohexaose I/II; p-LNH, para-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; IFLNH I/III, fucosyl-para-lacto-N-hexaose I/III; DFS-LNH, difucosylmonosialyllacto-N-hexaose; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose; TFLNH, trifucosyllacto-N-hexaose.
Table 9. Associations between HMOs and eating behaviors at 48 months (unadjusted for false discovery).
Table 9. Associations between HMOs and eating behaviors at 48 months (unadjusted for false discovery).
SampleEating BehaviorHMOEstimatep-Values
Full
Cohort		Enjoyment of FoodLNFP II−0.1190.014
LNDFH II−0.1250.035
Emotional overeatingLNH−0.0710.046
LNnH−0.0880.024
IFLNH III−0.0700.037
Satiety responsivenessLNFP II0.0100.017
DFS-LNnH−0.0850.023
Slowness in eatingS-LNH−0.0920.041
Food fussinessLNFP V0.2000.019
LNnH−0.1060.038
S-LNH0.1390.004
DFS-LNnH−0.1410.005
Food responsivenessTotal Sialylation0.0840.040
6′-SL0.1140.003
IFLNH I0.0940.047
SecretorsEnjoyment of food6′-SL0.1320.008
Emotional overeatingMFpLNH IV−0.1530.042
IFLNH III−0.0850.047
Slowness in eatingLNH−0.1230.037
Food fussinessTotal nonfucosylated neutral0.1430.029
LNT+LNnT0.1660.023
p-LNH0.1120.041
S-LNH−0.1310.006
DFS-LNnH−0.1210.012
Food responsivenessTotal Sialylation0.1160.010
Total nonfucosylated neutral−0.1260.026
6′-SL0.1200.010
Non-SecretorsEnjoyment of food3-FL−0.1650.032
LNFP II−0.1430.026
LNFP V−0.2460.016
LNDFH II−0.1920.012
Emotional overeatingLNH−0.1190.024
LNnH−0.2360.020
S-LNnH II−0.1760.036
Satiety response3-FL0.1250.039
LNFP II0.1040.041
Emotional undereatingLNH−0.2100.022
Food fussiness3-FL0.2340.014
LNFP V0.3670.003
LNDFH I0.8280.009
LNDFH II0.2220.021
LNH−0.1550.050
LNnH−0.3440.023
Abbreviations: 3-FL, 3-fucosyllactose; 6′-SL, 6′-sialyllactose; LNnT, lacto-N-neotetraose; LNT, lacto-N-tetrose; LNFP II/V, lacto-N-fucopentaose-II/V; LNDFH I/II, lacto-N-difucohexaose I/II; LNH, lacto-N-hexaose; LNnH, lacto-N-neohexaose; S-LNH, sialyl-lacto-N-hexaose; S-LNnH II, sialyllacto-N-neohexaose II; MFpLNH IV, fucosyl-para-lacto-N-hexaose IV; IFLNH III, fucosyl-para-lacto-N-hexaose  III; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose.
Table 10. Statistically significant associations between HMOs and infant behaviors after applying FDR correction for multiple testing.
Table 10. Statistically significant associations between HMOs and infant behaviors after applying FDR correction for multiple testing.
SampleTemperament Characteristics and Eating BehaviorsHMOEstimateFDR
Adjusted p-Values
Full CohortSurgency (3 mo)IFLNH III0.1640.08
Negative affectivity (18 mo)LNH−0.1230.02
Negative affectivity (48 mo)MFLNH I+III−0.2060.009
Emotional undereating (12 mo)6′-SL−0.1780.09
SecretorsSurgency (3 mo)IFLNH III0.2240.024
Emotional undereating (12 mo)6′-SL−0.250.014
Non-SecretorsNegative affectivity (18 mo)Total Sialylation−0.2670.10
Negative affectivity (18 mo)S-LNnH II−0.3070.10
Negative affectivity (18 mo)IFLNH III−0.1590.10
Emotional overeating (12 mo)DFS-LNnH1.4820.08
Abbreviations: mo, month; 6′-SL, 6′-sialyllactose; IFLNH III, fucosyl-para-lacto-N-hexaose III; LNH, lacto-N-hexaose; MFpLNH I+III, fucosyl-para-lacto-N-hexaose I+III; S-LNnH II, sialyllacto-N-neohexaose II; DFS-LNnH, difucosylmonosialyllacto-N-neohexaose.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Fan, Y.; Bost, K.F.; Donovan, S.M. Human Milk Oligosaccharide Composition at 6 Weeks Is Associated with Temperament and Eating Behaviors of Children in the STRONG Kids 2 Cohort Through 4 Years of Age. Nutrients 2025, 17, 2080. https://doi.org/10.3390/nu17132080

AMA Style

Fan Y, Bost KF, Donovan SM. Human Milk Oligosaccharide Composition at 6 Weeks Is Associated with Temperament and Eating Behaviors of Children in the STRONG Kids 2 Cohort Through 4 Years of Age. Nutrients. 2025; 17(13):2080. https://doi.org/10.3390/nu17132080

Chicago/Turabian Style

Fan, Yuting, Kelly F. Bost, and Sharon M. Donovan. 2025. "Human Milk Oligosaccharide Composition at 6 Weeks Is Associated with Temperament and Eating Behaviors of Children in the STRONG Kids 2 Cohort Through 4 Years of Age" Nutrients 17, no. 13: 2080. https://doi.org/10.3390/nu17132080

APA Style

Fan, Y., Bost, K. F., & Donovan, S. M. (2025). Human Milk Oligosaccharide Composition at 6 Weeks Is Associated with Temperament and Eating Behaviors of Children in the STRONG Kids 2 Cohort Through 4 Years of Age. Nutrients, 17(13), 2080. https://doi.org/10.3390/nu17132080

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop